Esperion Therapeutics Inc (NAS:ESPR)
$ 2.12 0.12 (6%) Market Cap: 415.99 Mil Enterprise Value: 472.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Esperion Therapeutics Inc at Jefferies Virtual London Healthcare Conference Transcript

Nov 18, 2020 / 02:40PM GMT
Release Date Price: $29.14 (-3.29%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Hi, everyone. Good morning, good afternoon, depending on where you are in the world. I'm Michael Yee, and I'm excited to host Esperion with us here on this fireside chat at the Jefferies Virtual Lending Global Conference.

With us today, of course, we have the President and CEO of Esperion, Tim Mayleben. We also have the CFO Rick Bartram on with us.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

I would love to just start off, Tim, maybe just from a high level, and say congrats on approval and launch, particularly during a COVID environment. I think that deserves recognition, and it's certainly a testament to your guys' ability to execute.

With all that said, of course, that has come with challenges with other companies as well that we have talked to during COVID. So maybe you could just make some opening comments about the state of the launch this year, the pluses and the minuses during the COVID environment and how

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot